Welcome to Embel Bioscience, your trusted source for research-grade collagen products in North America. Our advanced collagen technology—originally developed in collaboration with the RWTH Aachen University- empowers us to bridge the gap between research and medical applications. Our mission is to provide high-quality collagen materials that support groundbreaking research and pave the way for future medical innovations.
Since our inception, our company has been working towards establishing a consistent, advanced manufacturing technique for collagen production. This has led to the successful initiation of multiple clinical trials, with our collagen products demonstrating safe and effective applications in human clinical studies—without any reported adverse events.
Our flagship product, PuriCollax™, a rat-tail sourced Collagen Type 1, is a clinically proven, versatile material that supports transformative advancements in medicine, including liquid-on-a-chip technologies, tissue engineering, and organ development. With a unique manufacturing process that ensures consistency batch after batch since 2003, our collagen has become a reliable tool for researchers and clinicians alike.
Since 2005, our products have served critical applications in orthopedics, sports medicine, and traumaology. Our unique 3D Collagen Type 1 Matrix provides an exceptional three-dimensional cultivation environment, enabling the repair, testing, regeneration, and restoration of natural tissue and organ function. This makes it an invaluable resource for both modern manufacturing and personalized medicine.
Proven in medical-in-human use since 2004 with no adverse events, our 3D collagen matrix stands out for its high biocompatibility, superior purity, and unmatched consistency. These qualities are a direct result of our unique and innovative manufacturing process, which has set the standard for collagen production for over two decades.
At Embel Bioscience, we are proud to support the future of medicine with collagen products that combine proven performance, safety, and innovation.
Our mission is to deliver top-tier collagen products that support cutting-edge research and medical advancements. We are dedicated to fostering innovation and excellence in the biotechnology sector, ensuring that our products meet the highest standards of quality and safety.
We collaborate closely with our customers and seek strategic partnerships to amplify technological advancements, drive innovation, and create a lasting impact on the future of science and health globally.
Our North American operations are headquartered in Spokane, Washington, U.S., with a dedicated sales office located in Vancouver, Canada. This strategic setup allows us to maintain a strong presence in North America, enhancing our operational capabilities and customer support across the region.
While we leverage the cost efficiencies and advanced technologies of our manufacturing operations in Zhejiang, China, our North American team is committed to delivering the highest standards of service and innovation to our local partners and clients.
At Embel BioScience, we bridge the gap between research and commercialization by making high-grade rat tail collagen accessible to researchers. Unlike anything currently available on the market, our research grade collagen bridges to clinical-grade collagen that ensures consistency and reliability throughout the development lifecycle.
By providing researchers with the same quality of collagen used in clinical applications, we eliminate unexpected delays when breakthroughs are ready for commercialization. Our products empower researchers and medical professionals to focus on innovation, confident that their materials will perform to the highest standards at every stage.
At Embel Bioscience, we are committed to advancing the development of high-quality collagen-based solutions for medical and cosmetic applications. We are excited to collaborate with forward-thinking companies and research institutions to bring innovative and compliant products to the North American market.
We seek strategic partnerships to co-develop cutting-edge medical devices and cosmetic solutions that meet the highest industry standards. By working together, we aim to expand product offerings, accelerate regulatory approval, and deliver transformative solutions to researchers, clinicians, and end-users.
To explore partnership opportunities, please contact us at partnerships@embelbio.com.
At Embel BioScience, our mission is to deliver top-tier collagen products that support cutting-edge research and medical advancements. We are dedicated to fostering innovation and excellence in the biotechnology sector, ensuring that our products meet the highest standards of quality and safety. We collaborate closely with our customers to not just conduct business, but to transform the landscape of scientific innovation and improve health outcomes worldwide.
Our North American operations are headquartered in Spokane, Washington, U.S., with a dedicated sales office located in Vancouver, Canada. This strategic setup allows us to maintain a strong presence in North America, enhancing our operational capabilities and customer support across the region. While we leverage the cost efficiencies and advanced technologies of our manufacturing operations in Zhejiang, China, our North American team is committed to delivering the highest standards of service and innovation to our local partners and clients.
From research-grade to implant-grade collagen, our products are designed to meet the highest standards of purity and consistency comparing to other options on the market. We are committed to providing reliable, effective solutions tailored to the needs of researchers and industry professionals. Our dedication to precision and affordability ensures that every product delivers consistent performance, empowering breakthroughs in research, bioprinting, and tissue engineering.
Our vision is to become the leading supplier of research-grade collagen in North America, fostering collaborations with universities, research institutions, and industry partners. We aim to drive advancements in biotechnology through our products, supporting groundbreaking research and contributing to the development of new medical treatments.
To further increase our impact in the North American region, Embel BioScience is actively seeking partnerships with innovative companies and research institutions. We are particularly interested in collaborating on the development of medical devices and cosmetics for FDA approval. By partnering with industry leaders, we aim to expand our product offerings and bring cutting-edge, compliant solutions to the market.
At Embel Bioscience, we combine cutting-edge manufacturing technology with a commitment to innovation and quality, delivering advanced biomaterials tailored to your needs. Our expertise in regenerative medicine and dedication to customer success ensure reliable, high-performance solutions for your most challenging applications.
Ultra-pure, low-endotoxin, high level of cross-link collagen for research and clinical breakthroughs.
Delivering premium-grade collagen with uncompromising standards at competitive prices.
Soluble collagen with intact triple-helical conformation and telopeptides to ensure fibril formation.
We seek partnership with industry pioneers to create FDA-compliant innovations.
Proven success in clinical trials across Asia and Europe.
Delivering precision-engineered collagen for reliable results in 3D bioprinting and tissue engineering.
Embel BioScience is committed to delivering high-quality, research-grade collagen products that drive innovation in scientific research and medical applications.
Quick response to North American client needs.
Products that exceed industry standards.
High purity, low endotoxin, ideal for research and clinical use.
We partner with innovators to develop FDA-compliant products, expanding our line.
Extensive clinical use in Asia and Europe.
Responsive to various external stimuli, clinically successful in multiple countries.
© 2025 Embel Bioscience, All Rights Reserved